{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:43:15Z","timestamp":1773409395736,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.cancergencyto.2010.02.003","type":"journal-article","created":{"date-parts":[[2010,5,14]],"date-time":"2010-05-14T08:29:54Z","timestamp":1273825794000},"page":"76-80","source":"Crossref","is-referenced-by-count":25,"title":["Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenetic and prognostic implications"],"prefix":"10.1016","volume":"199","author":[{"given":"Alfonso","family":"Zaccaria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Testoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Luatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Tonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Marzocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Baldazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Stacchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Gamberini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Castagnetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianantonio","family":"Rosti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Azzena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cavazzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Cianciulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Dalsass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Donti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Giugliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Gozzetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Grimoldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Ronconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Spedicato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Zanatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Baccarani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2010.02.003_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia","volume":"341","author":"Faderl","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib2","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1182\/blood-2002-09-2790","article-title":"Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy","volume":"101","author":"Cortez","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood-2007-07-103523","article-title":"Favorable long-term follow-up results over 6 years response, survival and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interpheron-\u03b1 treatment","volume":"111","author":"Hochhaus","year":"2008","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.cancergencyto.2010.02.003_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/10428199309047856","article-title":"The cytogenetics scenario of chronic myeloid leukemia","volume":"11","author":"Mitelman","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib5","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/sj.leu.2402877","article-title":"Simultaneous occurrence of a t(9;22) (Ph) with t(2;11) in a patient with CML and emergence of a new clone with t(9;22) alone after Imatinib mesylate treatment","volume":"17","author":"Royer-Pokora","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1034\/j.1600-0609.2003.00148.x","article-title":"Emergence of Ph negative clones in chronic myeloid leukemia (CML) patients in complete cytogenetic remission after therapy with imatinib mesilate (STI)","volume":"71","author":"Gozzetti","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2141.2006.06285.x","article-title":"Occurrence of the same chromosome abnormalities in Ph+ and Ph\u2212 cells in chronic myeloid leukemia. Evidence of a secondary origin of the Ph chromosome?","volume":"135","author":"Donti","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib8","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3324\/haematol.10783","article-title":"Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukaemia","volume":"92","author":"Zaccaria","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.bmt.1701491","article-title":"Autologous peripheral blood stem cell transplantation in acute myeloblastic leukemia and myelodysplastic syndrome patients: evaluation of tumor cell contamination of leukaphereses by cytogenetic and molecular methods","volume":"22","author":"Testoni","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib10","series-title":"ISCN: an international system for human cytogenetic nomenclature","year":"1995"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib11","series-title":"ISCN: an international system for human cytogenetic nomenclature","year":"2005"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib12","series-title":"ISCN: an international system for human cytogenetic nomenclature","year":"2009"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1182\/blood.V72.1.294.294","article-title":"Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome\u2013positive chronic granulocytic leukemia","volume":"72","author":"Sokal","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib14","first-page":"1163","article-title":"Further evidence for the existence of clonal Ph-negative stage in some cases of Ph-positive chronic myelocyitic leukemia","volume":"7","author":"Raskind","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib15","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1182\/blood.V66.6.1326.1326","article-title":"Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival","volume":"66","author":"Kantarjian","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib16","first-page":"143","article-title":"Prognostic significance of additional abnormalities in newly diagnosed patients with Philadelphia chromosome\u2013positive chronic myeloid leukaemia treated with interferon alpha: a Cancer and Leukemia Group B study","volume":"25","author":"Farag","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3324\/haematol.12588","article-title":"Monitoring treatment of chronic myeloid leukemia","volume":"93","author":"Baccarani","year":"2008","journal-title":"Haematologica"},{"issue":"Suppl 4","key":"10.1016\/j.cancergencyto.2010.02.003_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/annonc\/mdp143","article-title":"ESMO Guidelines Working Group. Chronic myelogenous leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up","volume":"20","author":"Baccarani","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2008.12.013","article-title":"Imatinib mesylate efficacy in 72 previously treated Philadelphia-positive chronic myeloid leukemia patients with and without additional chromosomal changes: single-center results","volume":"191","author":"Holzerov\u00e1","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib20","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/sj.leu.2402741","article-title":"Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy","volume":"16","author":"Hochhaus","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.02.003_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cancergencyto.2005.05.004","article-title":"Duplication of the Ph-chromosome as a possible mechanism of resistance to imatinib mesylate in patients with chronic myelogenous leukemia","volume":"163","author":"Ossard- Receveur","year":"2005","journal-title":"Cancer Genet Cytogenet"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810000579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810000579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T17:17:20Z","timestamp":1591291040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460810000579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0165460810000579"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.02.003","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}